Cheng‐Pang Hsu

Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer

Jean‐Charles Soria, Egbert F. Smit, David Khayat et al. · Journal of Clinical Oncology · 2010 · 222 citations

Medicine, Oncology, Pharmacology +17

Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies

Jennifer Dong, David H. Salinger, Christopher J. Endres et al. · Clinical Pharmacokinetics · 2011 · 154 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors

Roy S. Herbst, Razelle Kurzrock, David S. Hong et al. · Clinical Cancer Research · 2010 · 139 citations

Pharmacy, Oncology, Pharmacology +16

Beta Cyclodextrins Enhance Adenoviral-Mediated Gene Delivery to the Intestine

Maria A. Croyle, Blake J. Roessler, Cheng‐Pang Hsu et al. · Pharmaceutical Research · 1998 · 67 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +11

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs

Hyo-Kyung Han, Julie K. Rhie, Doo‐Man Oh et al. · Journal of Pharmaceutical Sciences · 1999 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7